---
output: 
  md_document:
    variant: gfm  # GitHub-flavored Markdown (for better rendering on GitHub)
    preserve_yaml: true  # Keep YAML metadata in the output
params:
  trial: ''
---

**NCT06103864**

<div style="padding: 5px 5px 5px 0px; font-size: 1.20em; font-weight: 500; color: #2E4A7F; text-align: left; margin-bottom: 20px">

(TROPION-Breast05) Estudo de Fase III comparando Dato-DXd com/sem
durvalumabe versus quimioterapia mais pembrolizumabe em pacientes com
câncer de mama triplo-negativo metastático PD-L1 positivo.

</div>

**Título Oficial:** A Phase III, Open-label, Randomised Study of
Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared
With Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel
or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in
Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic
Triple-negative Breast Cancer (TROPION-Breast05)

**Desenho do Estudo:** Estudo Clinico Fase III

**Resumo do Estudo:** Este estudo de Fase III, aberto e randomizado,
avalia a eficácia e segurança do Datopotamab Deruxtecan (Dato-DXd) com
ou sem Durvalumab, em comparação com a escolha de quimioterapia do
investigador (Paclitaxel, Nab-paclitaxel ou Gemcitabina + Carboplatina)
combinada com Pembrolizumab. A população-alvo inclui pacientes com
câncer de mama triplo-negativo localmente recorrente inoperável ou
metastático positivo para PD-L1. O estudo é conduzido internacionalmente
em vários centros para determinar o regime de tratamento mais eficaz
para este grupo específico de pacientes.

**Paciente Ideal:** Este estudo de Fase III, aberto e randomizado,
avalia a eficácia e segurança do Datopotamab Deruxtecan (Dato-DXd) com
ou sem Durvalumab, em comparação com a escolha de quimioterapia do
investigador (Paclitaxel, Nab-paclitaxel ou Gemcitabina + Carboplatina)
combinada com Pembrolizumab. A população-alvo inclui pacientes com
câncer de mama triplo-negativo localmente recorrente inoperável ou
metastático positivo para PD-L1. O estudo é conduzido internacionalmente
em vários centros para determinar o regime de tratamento mais eficaz
para este grupo específico de pacientes.

Para mais informações, acesse as informações do estudo no
*clinicaltrials.gov* no seguinte
[link](https://clinicaltrials.gov/ct2/show/NCT06103864)

**Centros Participantes**

Se você conhece algum centro participante que não esteja listado, clique
em
<span style="color: #2E4A7F; margin-left: 2px; padding: 2px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.6em">[ADICIONAR
CENTRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06103864&location_id=N%2FA&location_full_name=N%2FA&form_type=Adicionar%20Centro%7D)</span>.

<div style="margin-bottom: 8px; margin-left: 5px; padding: 8px; max-width: 300px; background-color: #f3f2f1; border-radius: 8px;">

<div style="margin-left: 10px;">

    <span 
      style="border: 0.5px solid black; background-color: #9fd89f; width: 15px; height: 15px; display: inline-block; margin-right: 5px; border-radius: 50%;"></span>
    <p style="display: inline;">Recrutamento Ativo</p>

</div>

<div style="margin-left: 10px;">

    <span 
      style="border: 0.5px solid black; background-color: #fef7b2; width: 15px; height: 15px; display: inline-block; margin-right: 5px; border-radius: 50%;"></span>
    <p style="display: inline;">Ainda Não Recrutando</p>

</div>

<div style="margin-left: 10px;">

    <span 
      style="border: 0.5px solid black; background-color: #f4bfab; width: 15px; height: 15px; display: inline-block; margin-right: 5px; border-radius: 50%;"></span>
    <p style="display: inline;">Recrutamento Suspenso/Encerrado</p>

</div>

</div>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
CNI (Centro Não-Identificado) Research Site 74000-000, Goiânia, -
<span style="color: #2E4A7F; margin-left: 2px; padding: 2px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.6em">[IDENTIFICAR
CENTRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06103864&location_id=RESEARCHSITEGOIANIA74000000BRAZIL&location_full_name=%28Centro%20N%C3%A3o-Identificado%29%2C%20Research%20Site%2074000-000%2C%20Goi%C3%A2nia%2C%20%20-%20&form_type=Identificar%20Centro)</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
PE Real Hospital Português 52010-075, Recife
<span style="color: #2E4A7F; margin-left: 2px; padding: 2px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.6em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06103864&location_id=RESEARCHSITERECIFE52010075BRAZIL&location_full_name=Real%20Hospital%20Portugu%C3%AAs%2C%2052010-075%2C%20Recife&form_type=Reportar%20Erro)</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
PI Oncoclínica Oncologistas Associados 64049-200, Teresina
<span style="color: #2E4A7F; margin-left: 2px; padding: 2px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.6em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06103864&location_id=RESEARCHSITETERESINA64049200BRAZIL&location_full_name=Oncocl%C3%ADnica%20Oncologistas%20Associados%2C%2064049-200%2C%20Teresina&form_type=Reportar%20Erro)</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
PR Hospital Universitário Evangélico Mackenzie 80730-150, Curitiba
<span style="color: #2E4A7F; margin-left: 2px; padding: 2px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.6em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06103864&location_id=RESEARCHSITECURITIBA80730150BRAZIL&location_full_name=Hospital%20Universit%C3%A1rio%20Evang%C3%A9lico%20Mackenzie%2C%2080730-150%2C%20Curitiba&form_type=Reportar%20Erro)</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
RS Centro de Pesquisa Clínica - HCPA 90035-007, Porto Alegre
<span style="color: #2E4A7F; margin-left: 2px; padding: 2px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.6em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06103864&location_id=RESEARCHSITEPORTOALEGRE90035003BRAZIL&location_full_name=Centro%20de%20Pesquisa%20Cl%C3%ADnica%20-%20HCPA%2C%2090035-007%2C%20Porto%20Alegre&form_type=Reportar%20Erro)</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
SC CEPON 88034-000, Florianópolis
<span style="color: #2E4A7F; margin-left: 2px; padding: 2px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.6em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06103864&location_id=RESEARCHSITEFLORIANOPOLIS88034000BRAZIL&location_full_name=CEPON%2C%2088034-000%2C%20Florian%C3%B3polis&form_type=Reportar%20Erro)</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
SC Catarina Pesquisa Clínica 88301-220, Itajaí
<span style="color: #2E4A7F; margin-left: 2px; padding: 2px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.6em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06103864&location_id=RESEARCHSITEITAJAI88301220BRAZIL&location_full_name=Catarina%20Pesquisa%20Cl%C3%ADnica%2C%2088301-220%2C%20Itaja%C3%AD&form_type=Reportar%20Erro)</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
SP Centro de Pesquisa Pérola 01317-000, São Paulo
<span style="color: #2E4A7F; margin-left: 2px; padding: 2px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.6em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06103864&location_id=RESEARCHSITESAOPAULO01317001BRAZIL&location_full_name=Centro%20de%20Pesquisa%20P%C3%A9rola%2C%2001317-000%2C%20S%C3%A3o%20Paulo&form_type=Reportar%20Erro)</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
SP Instituto de Pesquisa Amelia Bernardini Cutrale - Hospital de Amor
14784-400, Barretos
<span style="color: #2E4A7F; margin-left: 2px; padding: 2px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.6em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06103864&location_id=RESEARCHSITEBARRETOS14784400BRAZIL&location_full_name=Instituto%20de%20Pesquisa%20Amelia%20Bernardini%20Cutrale%20-%20Hospital%20de%20Amor%2C%2014784-400%2C%20Barretos&form_type=Reportar%20Erro)</span>

<span style="border: 0.5px solid black; display: inline-block; width: 12px; height: 12px; border-radius: 50%; margin-right: 10px; padding-bottom: 0px; background-color: #9fd89f;"></span>
SP Instituto do Câncer do Estado de São Paulo - ICESP Unidade São Paulo
01246-000, São Paulo
<span style="color: #2E4A7F; margin-left: 2px; padding: 2px; background-color: #f3f2f1; border-radius: 8px; font-weight: 500; font-size: 0.6em">[REPORTAR
ERRO](https://flazar.shinyapps.io/formsapp?study_nct_id=NCT06103864&location_id=RESEARCHSITESAOPAULO01246000BRAZIL&location_full_name=Instituto%20do%20C%C3%A2ncer%20do%20Estado%20de%20S%C3%A3o%20Paulo%20-%20ICESP%20Unidade%20S%C3%A3o%20Paulo%2C%2001246-000%2C%20S%C3%A3o%20Paulo&form_type=Reportar%20Erro)</span>
